Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

4.4K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.4K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

203
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
203
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

200
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
200
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

269
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
269
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

146
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
146
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

293
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
293

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The predictive value of fresh embryo transfer pregnancy results on frozen embryo transfer outcomes: a cohort study.

Frontiers in endocrinology·2026
Same author

Global mining has undermined forest conservation within and beyond protected areas.

Nature communications·2026
Same author

ASMem: Anchor sparse memory for multi-domain knowledge editing of large language models.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

FOXK1: a multifaceted regulator in metabolic reprogramming and disease progression.

Biology direct·2026
Same author

An ultrasensitive aptamer-based fluorescent biosensor for luteinizing hormone with mutually orthogonal DNAzyme and self-replication CHA amplification.

Analytical and bioanalytical chemistry·2026
Same author

How Experiences and Education Impact Undergraduate Nursing Student Preparedness to Provide Primary Palliative Care: A Longitudinal, Multi-Site Study in the United States.

The American journal of hospice & palliative care·2026
Same journal

Overlapping gut microbiome signatures in aging and disease are characterized by enrichment of medication-associated oral microbes in the gut.

FEBS letters·2026
Same journal

Csk binding to integrin β3 is regulated by tyrosine and threonine phosphorylation of β3.

FEBS letters·2026
Same journal

Mixed-class J-domain protein scaffolds promote expanded aggregate handling and multivalent Hsp70 engagement during functional disaggregase assembly.

FEBS letters·2026
Same journal

Design and analysis strategies for robust microbiome ageing research.

FEBS letters·2026
Same journal

Reconstructing enzyme evolution by protein engineering.

FEBS letters·2026
Same journal

Three phosphatase families form a community: The phosphohydrolases that act upon inositol pyrophosphates.

FEBS letters·2026
See all related articles

Related Experiment Video

Updated: Dec 25, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.9K

Multi-network logistic matrix factorization for metabolite-disease interaction prediction.

Yingjun Ma1,2, Tingting He1,3, Xingpeng Jiang1,3

  • 1School of Computer, Central China Normal University, Wuhan, China.

FEBS Letters
|April 5, 2020
PubMed
Summary
This summary is machine-generated.

We developed a new computational model, multiple-network logistic matrix factorization (MN-LMF), to predict metabolite-disease interactions. This method accurately identifies potential links, aiding in disease diagnosis and treatment, especially for novel conditions and metabolites.

Keywords:
Kernel neighborhood similaritydisease similaritylogistic matrix factorizationmetabolite similaritymetabolite-disease interaction

More Related Videos

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.1K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K

Related Experiment Videos

Last Updated: Dec 25, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.9K
Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.1K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.0K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Systems biology

Background:

  • Identifying metabolite-disease interactions is crucial for disease diagnosis, prevention, and treatment.
  • Existing methods struggle with novel diseases and metabolites due to limited known associations.
  • Integrating diverse omics data can enhance the prediction of these complex relationships.

Purpose of the Study:

  • To propose a novel computational model, multiple-network logistic matrix factorization (MN-LMF), for predicting metabolite-disease interactions.
  • To improve the prediction accuracy for both known and unknown metabolite-disease associations.
  • To address the challenge of identifying interactions for new diseases and metabolites.

Main Methods:

  • Constructing disease and metabolite similarity networks by integrating heterogeneous omics data.
  • Employing modified logistic matrix factorization to combine similarity networks with known interaction data.
  • Developing a computational framework for predicting potential metabolite-disease interactions.

Main Results:

  • MN-LMF demonstrates high accuracy in predicting metabolite-disease interactions.
  • The proposed model outperforms existing state-of-the-art methods in prediction performance.
  • Case studies confirm the model's effectiveness in inferring unknown interactions for novel diseases.

Conclusions:

  • MN-LMF is an effective computational tool for predicting metabolite-disease interactions.
  • The model shows significant promise for advancing disease diagnosis and therapeutic strategies.
  • This approach facilitates the discovery of novel metabolite-disease links, particularly in understudied areas.